Determination of the Expression of PD-L1 in the Morphologic Spectrum of Renal Cell Carcinoma

Immunotherapy is reportedly an effective form of therapy for some advanced cancers such as lung adenocarcinoma, malignant melanoma and colorectal adenocarcinoma. In renal cell carcinoma (RCC), the role of immunotherapy is under investigation. Programmed Death-Ligand 1 (PD-L1) is a molecule expressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Beatriz, Gil, Sara, Naizhen, Xu, Kruhlak, Michael J, Linehan, W Marston, Srinivasan, Ramaprasad, Merino, Maria J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150459/
https://www.ncbi.nlm.nih.gov/pubmed/32284756
http://dx.doi.org/10.7150/jca.35738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150459/
https://www.ncbi.nlm.nih.gov/pubmed/32284756
http://dx.doi.org/10.7150/jca.35738

Ejemplares similares